美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA209622"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
68001-541-36 68001-541 HUMAN PRESCRIPTION DRUG Bortezomib Bortezomib INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION INTRAVENOUS; SUBCUTANEOUS 20220731 N/A ANDA ANDA209622 BluePoint Laboratories BORTEZOMIB 3.5 mg/3.5mL 1 VIAL, SINGLE-USE in 1 CARTON (68001-541-36) / 3.5 mL in 1 VIAL, SINGLE-USE
72205-183-01 72205-183 HUMAN PRESCRIPTION DRUG Bortezomib Bortezomib INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION INTRAVENOUS; SUBCUTANEOUS 20220727 N/A ANDA ANDA209622 Novadoz Pharmaceuticals LLC BORTEZOMIB 3.5 mg/3.5mL 1 VIAL, SINGLE-USE in 1 CARTON (72205-183-01) / 3.5 mL in 1 VIAL, SINGLE-USE
83090-008-01 83090-008 HUMAN PRESCRIPTION DRUG Bortezomib Bortezomib INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION INTRAVENOUS; SUBCUTANEOUS 20230715 N/A ANDA ANDA209622 Sintetica US LLC BORTEZOMIB 3.5 mg/3.5mL 1 VIAL, SINGLE-DOSE in 1 CARTON (83090-008-01) / 3.5 mL in 1 VIAL, SINGLE-DOSE
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase